SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-006326
Filing Date
2018-08-03
Accepted
2018-08-03 11:30:05
Documents
61
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q imgn-20180630x10q.htm 10-Q 1473167
2 EX-10.1 imgn-20180630ex1012f6e53.htm EX-10.1 61259
3 EX-31.1 imgn-20180630ex3118c03d9.htm EX-31.1 11542
4 EX-31.2 imgn-20180630ex312e863af.htm EX-31.2 11584
5 EX-32 imgn-20180630xex32.htm EX-32 10301
  Complete submission text file 0001558370-18-006326.txt   9283786

Data Files

Seq Description Document Type Size
6 EX-101.INS imgn-20180630.xml EX-101.INS 2581414
7 EX-101.SCH imgn-20180630.xsd EX-101.SCH 50984
8 EX-101.CAL imgn-20180630_cal.xml EX-101.CAL 40229
9 EX-101.DEF imgn-20180630_def.xml EX-101.DEF 282074
10 EX-101.LAB imgn-20180630_lab.xml EX-101.LAB 464307
11 EX-101.PRE imgn-20180630_pre.xml EX-101.PRE 440939
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
IMMUNOGEN INC (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-17999 | Film No.: 18990845
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1